Coloplast A/S (OTCMKTS:CLPBY) Sees Unusually-High Trading Volume After Analyst Upgrade

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw unusually-strong trading volume on Thursday after Sanford C. Bernstein upgraded the stock to a hold rating. Approximately 1,386,759 shares changed hands during trading, an increase of 241% from the previous session’s volume of 407,150 shares.The stock last traded at $8.60 and had previously closed at $8.48.

Coloplast A/S Price Performance

The business has a fifty day moving average price of $8.74 and a 200 day moving average price of $9.13. The company has a market cap of $19.40 billion, a price-to-earnings ratio of 35.88, a PEG ratio of 0.82 and a beta of 0.26. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.00 and a current ratio of 1.61.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, November 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. Coloplast A/S had a net margin of 13.01% and a return on equity of 24.99%. As a group, research analysts anticipate that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.